https://curecurrent.com/trials/abilify-maintena-pms-in-schizophrenia-patients-or-bipolar-1-disorder-122681 https://curecurrent.com/trials/assessment-of-the-efficacy-of-a-fatigue-management-therapy-in-schizophrenia-122682 https://curecurrent.com/trials/a-safety-tolerability-and-pharmacokinetics-clinical-trial-of-jx11502ma-capsule-122683 https://curecurrent.com/trials/the-effect-of-psychoeducation-program-on-healthy-living-behaviors-122684 https://curecurrent.com/trials/6-month-extension-trial-of-asenapine-with-olanzapine-in-negative-symptoms-patients-who-completed-the-first-6-month-trial-122685 https://curecurrent.com/trials/study-of-asenapine-in-elderly-subjects-with-psychosis-a7501021-p05717-122686 https://curecurrent.com/trials/a-trial-to-determine-whether-two-differing-strength-tablets-3-x-5-mg-versus-1-x-15-mg-of-sublingually-org-5222-asenapine-122687 https://curecurrent.com/trials/6-month-extension-trial-of-asenapine-with-olanzapine-in-negative-symptom-patients-who-completed-the-protocol-25543-25544-122688 https://curecurrent.com/trials/long-term-efficacy-and-safety-of-asenapine-using-haloperidol-as-a-positive-control-41513-completed-p05785-122689 https://curecurrent.com/trials/efficacy-and-safety-of-asenapine-compared-with-olanzapine-in-patients-with-persistent-negative-symptoms-of-schizophrenia-122690 https://curecurrent.com/trials/to-determine-long-term-efficacy-and-safety-of-asenapine-in-schizophrenic-patient-population-a7501012-completed-p05770-122691 https://curecurrent.com/trials/family-psychoeducation-for-adults-with-psychotic-disorders-in-tanzania-122692 https://curecurrent.com/trials/post-authorization-safety-surveillance-study-of-asenapine-in-participants-with-bipolar-disorder-p08307-122693 https://curecurrent.com/trials/prevalence-of-cardiovascular-disorders-in-patients-aged-40-and-more-with-schizophrenia-122694 https://curecurrent.com/trials/the-effects-of-cannabidiol-and-9-thc-in-humans-122695 https://curecurrent.com/trials/n-acetylcysteine-effects-on-tetrahydrocannabinol-122696 https://curecurrent.com/trials/social-cognitive-assessment-in-autism-and-schizophrenia-122697 https://curecurrent.com/trials/effects-of-integrated-moral-reasoning-development-intervention-for-management-of-violence-in-schizophrenia-122698 https://curecurrent.com/trials/l-arginine-study-for-persistent-symptoms-of-schizophrenia-122699 https://curecurrent.com/trials/exenatide-weekly-injections-as-an-adjunctive-treatment-in-patients-with-schizophrenia-122700 https://curecurrent.com/trials/evaluate-the-safety-tolerability-and-pharmacokinetic-profile-of-tpn672-tablets-maleate-in-patients-with-schizophrenia-122701 https://curecurrent.com/trials/oxytocin-or-galantamine-versus-placebo-for-the-treatment-of-negative-symptoms-and-cognitive-impairments-in-schizophrenia-122702 https://curecurrent.com/trials/the-efficacy-of-computerized-cognitive-remediation-therapy-for-chronic-schizophrenia-122703 https://curecurrent.com/trials/treatment-of-schizophrenia-with-l-tetrahydropalmatine-l-thp-a-novel-dopamine-antagonist-with-anti-inflammatory-and-antip-122704 https://curecurrent.com/trials/minocycline-and-tobacco-craving-in-smokers-with-schizophrenia-122705 https://curecurrent.com/trials/comparative-bioavailability-of-risperidone-122706 https://curecurrent.com/trials/varenicline-adjunctive-treatment-in-schizophrenia-122707 https://curecurrent.com/trials/study-evaluating-the-efficacy-and-safety-of-wid-rgc20-cariprazine-in-patients-with-schizophrenia-122708 https://curecurrent.com/trials/exploration-of-the-deep-transcranial-magnetic-stimulation-for-treatment-resistant-schizophrenia-122709 https://curecurrent.com/trials/maintain-the-efficacy-and-safety-in-treatment-of-schizophrenia-after-switching-to-long-acting-injectable-aripiprazole-fr-122710 https://curecurrent.com/trials/transcranial-alternating-current-stimulation-tacs-for-auditory-hallucinations-122711 https://curecurrent.com/trials/comparative-bioavailability-of-risperidone-122712 https://curecurrent.com/trials/study-of-cad-9303-in-subjects-with-schizophrenia-122713 https://curecurrent.com/trials/illness-management-and-recovery-for-veterans-with-severe-mental-illness-122714 https://curecurrent.com/trials/transcranial-magnetic-stimulation-for-the-treatment-of-auditory-hallucinations-in-schizophrenia-122715 https://curecurrent.com/trials/glutamate-reducing-interventions-in-schizophrenia-122716 https://curecurrent.com/trials/ontrack-an-online-role-playing-game-for-young-people-with-first-episode-psychosis-122717 https://curecurrent.com/trials/efficacy-of-chronic-disease-self-management-program-in-people-with-schizophrenia-122718 https://curecurrent.com/trials/the-synergistic-effect-of-hypoglycemic-index-diet-on-refractory-schizophrenia-122719 https://curecurrent.com/trials/the-impact-of-the-covid-19-pandemic-on-schizophrenia-patients-registered-with-the-community-mental-health-center-122720 https://curecurrent.com/trials/iti-007-lumateperone-tosylate-for-schizophrenia-122721 https://curecurrent.com/trials/improving-adherence-to-cognitive-rehabilitation-122722 https://curecurrent.com/trials/animal-assisted-therapy-in-the-residential-treatment-of-schizophrenia-and-addictions-122723 https://curecurrent.com/trials/evaluation-of-a-mindfulness-resiliency-training-program-for-refugees-living-in-jordan-122724 https://curecurrent.com/trials/an-integrated-program-for-the-treatment-of-first-episode-of-psychosis-122725 https://curecurrent.com/trials/psychodynamic-psychotherapy-for-psychosis-122726 https://curecurrent.com/trials/multiple-ascending-doses-of-pf-04958242-in-subjects-with-stable-schizophrenia-122727 https://curecurrent.com/trials/clozapine-use-pattern-in-the-province-of-seville-122728 https://curecurrent.com/trials/reducing-the-burden-of-chronic-psychotic-disorders-in-tanzania-capacity-122729 https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-treatment-for-schizophrenia-patients-with-auditory-hallucinations-122730 https://curecurrent.com/trials/pentoxifylline-add-on-therapy-for-schizophrenia-122731 https://curecurrent.com/trials/raloxifene-augmentation-in-patients-with-a-schizophrenia-spectrum-disorder-122732 https://curecurrent.com/trials/study-of-the-effects-of-pantoprazole-on-levels-of-prescribed-psychiatric-medications-122733 https://curecurrent.com/trials/study-of-the-effect-of-dosing-on-clozapine-levels-122734 https://curecurrent.com/trials/a-study-of-alks-3831-in-subjects-with-schizophrenia-and-alcohol-use-disorder-122735 https://curecurrent.com/trials/a-study-of-alks-3831-in-adults-with-schizophrenia-122736 https://curecurrent.com/trials/the-effect-of-the-psychoeducation-program-on-the-subjective-well-being-of-caregivers-122737 https://curecurrent.com/trials/integrated-care-including-assertive-community-treatment-in-early-psychosis-122738 https://curecurrent.com/trials/effects-of-oxytocin-on-negative-symptoms-and-social-cognition-in-schizophrenia-and-its-possible-mechanisms-122739 https://curecurrent.com/trials/adapting-critical-time-intervention-to-support-inpatient-medical-care-transition-122740 https://curecurrent.com/trials/a-study-of-a-remediation-program-of-social-cognition-in-schizophrenia-122741 https://curecurrent.com/trials/modulation-of-repetitive-transcranial-magnetic-stimulation-on-hippocampal-neurogenesis-and-functional-network-in-patient-122742 https://curecurrent.com/trials/the-effect-of-repetitive-transcranial-magnetic-stimulation-in-schizophrenia-122743 https://curecurrent.com/trials/implementation-of-digital-cbt-for-insomnia-in-first-episode-psychosis-122744 https://curecurrent.com/trials/involuntary-memories-investigation-in-schizophrenia-122745 https://curecurrent.com/trials/assessment-of-efficacy-of-a-psychological-therapy-in-inpatients-with-a-schizophrenic-psychosis-122746 https://curecurrent.com/trials/a-study-in-schizophrenic-patients-122747 https://curecurrent.com/trials/an-observational-study-on-atypical-antipsychotics-long-term-treatment-patients-with-schizophrenia-122748 https://curecurrent.com/trials/deep-transcranial-magnetic-stimulation-for-the-treatment-of-treatment-resistance-schizophrenia-122749 https://curecurrent.com/trials/sustained-attention-abilities-in-schizophrenia-122750 https://curecurrent.com/trials/early-identification-and-predictive-parsing-for-high-risk-group-of-schizophrenia-122751 https://curecurrent.com/trials/an-adaptive-phase-ii-iii-two-part-double-blind-randomized-placebo-controlled-dose-finding-multi-center-study-of-the-safe-122752 https://curecurrent.com/trials/correlation-between-cognitive-function-and-relapse-of-schizophrenia-regarding-dose-reduction-122753 https://curecurrent.com/trials/development-of-a-mobile-heath-augmented-brief-suicide-prevention-intervention-for-people-with-smi-122754 https://curecurrent.com/trials/a-trial-in-adult-participants-with-schizophrenia-treated-prospectively-for-6-months-with-abilify-mycite-122755 https://curecurrent.com/trials/group-training-for-social-skills-in-psychosis-122756 https://curecurrent.com/trials/neurobiological-effects-of-oxytocin-in-schizophrenia-122757 https://curecurrent.com/trials/self-management-training-and-automated-telehealth-to-improve-smi-health-outcomes-122758 https://curecurrent.com/trials/high-definition-transcranial-direct-current-stimulation-as-a-treatment-of-negative-symptoms-of-schizophrenia-122759 https://curecurrent.com/trials/study-evaluating-the-effects-of-multiple-doses-of-nsa-789-in-subjects-with-schizophrenia-or-schizoaffective-disorder-122760 https://curecurrent.com/trials/study-evaluating-the-effects-of-single-oral-doses-of-nsa-789-on-auditory-p50-suppression-in-schizophrenic-patients-122761 https://curecurrent.com/trials/study-of-ly2140023-in-schizophrenia-comparing-ly2140023-olanzapine-and-placebo-122762 https://curecurrent.com/trials/efficacy-and-mechanisms-of-low-intensity-focused-ultrasound-on-negative-symptoms-in-patients-with-schizophrenia-122763 https://curecurrent.com/trials/a-study-of-dose-response-relationship-and-the-evidence-based-multisensory-stimulation-intervention-122764 https://curecurrent.com/trials/the-gut-metagenome-research-of-schizophrenia-122765 https://curecurrent.com/trials/evaluation-of-a-psychoeducation-program-for-families-caregivers-of-schizophrenic-patients-randomized-study-in-two-arms-122766 https://curecurrent.com/trials/pharmacologically-augmented-cognitive-therapies-pacts-for-schizophrenia-122767 https://curecurrent.com/trials/schizophrenia-and-ptsd-project-health-interventions-and-risk-resilience-evaluation-sapphire-study-122768 https://curecurrent.com/trials/addition-of-ondansetron-to-ongoing-antipsychotic-treatment-for-schizophrenia-122769 https://curecurrent.com/trials/brain-effects-of-memory-training-in-early-psychosis-122770 https://curecurrent.com/trials/optimizing-and-individualizing-the-pharmacological-treatment-of-first-episode-schizophrenic-patients-122771 https://curecurrent.com/trials/dynamics-of-risk-perception-and-risk-behavior-in-alcohol-use-disorder-and-schizophrenia-122772 https://curecurrent.com/trials/the-effect-of-psycho-education-on-clinical-outcomes-among-patients-with-a-first-episode-psychosis-in-central-uganda-122773 https://curecurrent.com/trials/motivation-and-skills-support-mass-122774 https://curecurrent.com/trials/insight-enhancement-program-vs-metacognitive-training-for-psychosis-in-patients-with-schizophrenia-a-three-armed-compara-122775 https://curecurrent.com/trials/pharmacologic-modulation-of-hippocampal-activity-in-psychosis-122776 https://curecurrent.com/trials/cognitive-behaviour-therapy-for-voices-and-dissociation-122777 https://curecurrent.com/trials/the-effects-of-different-modalities-of-exercise-in-patients-with-schizophrenia-122778 https://curecurrent.com/trials/an-open-label-trial-of-tocilizumab-in-schizophrenia-122779 https://curecurrent.com/trials/prediction-of-relapse-in-schizophrenia-schizoaffective-disorder-with-smartphones-and-on-body-sensors-122780 https://curecurrent.com/trials/sulforaphane-to-reduce-symptoms-of-schizophrenia-122781 https://curecurrent.com/trials/treatment-response-in-schizophrenia-bridging-imaging-and-postmortem-studies-122782 https://curecurrent.com/trials/a-prospective-open-ended-multi-center-study-of-schizophrenia-patients-switching-to-zolodine-122783 https://curecurrent.com/trials/a-phase-3-long-term-safety-and-tolerability-study-of-alks-3831-in-adults-with-schizophrenia-122784 https://curecurrent.com/trials/cognitive-remediation-for-schizophrenia-122785 https://curecurrent.com/trials/improving-visual-attention-in-schizophrenia-122786 https://curecurrent.com/trials/improving-negative-symptoms-community-engagement-in-veterans-with-schizophrenia-122787 https://curecurrent.com/trials/cannabis-and-schizophrenia-self-medication-and-agonist-treatment-122788 https://curecurrent.com/trials/remediation-of-auditory-recognition-in-schizophrenia-with-tdcs-122789 https://curecurrent.com/trials/nonverbal-synchrony-therapeutic-alliance-and-treatment-engagement-in-first-episode-schizophrenia-122790 https://curecurrent.com/trials/a-study-to-evaluate-abt-126-for-the-treatment-of-cognitive-deficits-in-schizophrenia-122791 https://curecurrent.com/trials/a-phase-2-study-to-evaluate-abt-126-for-the-treatment-of-cognitive-deficits-in-schizophrenia-122792 https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-efficacy-of-180-mg-subcutaneous-risperidone-from-6-mg-oral-risperidone-122793 https://curecurrent.com/trials/a-multiple-ascending-dose-trial-of-cvl-231-in-subjects-with-schizophrenia-122794 https://curecurrent.com/trials/trial-of-stimulus-response-potentiation-in-schizophrenia-122795 https://curecurrent.com/trials/improving-access-to-early-psychosis-coordinated-specialty-care-122796 https://curecurrent.com/trials/study-of-m-resist-an-m-health-program-for-treatment-resistant-schizophrenia-122797 https://curecurrent.com/trials/the-effects-of-three-different-modalities-of-exercise-in-patients-with-schizophrenia-122798 https://curecurrent.com/trials/sleep-disturbances-in-patients-with-psychotic-symptoms-akusleep-122799 https://curecurrent.com/trials/motivational-interviewing-in-patients-with-schizophrenia-122800 https://curecurrent.com/trials/reducing-duration-of-untreated-psychosis-through-rapid-identification-and-engagement-122801 https://curecurrent.com/trials/cbd-cigarettes-instead-of-normal-cigarettes-as-innovative-treatment-for-schizophrenia-122802 https://curecurrent.com/trials/long-term-safety-of-spd489-when-added-to-stable-doses-of-antipsychotic-medications-in-clinically-stable-adults-with-nega-122803 https://curecurrent.com/trials/spd489-low-dose-and-high-dose-ranges-when-added-to-stable-doses-of-antipsychotic-medications-in-clinically-stable-adults-122804 https://curecurrent.com/trials/adjunctive-spd489-to-antipsychotic-medication-in-clinically-stable-adults-with-persistent-predominant-negative-symptoms-122805 https://curecurrent.com/trials/comparison-of-maintenance-ect-versus-clozapine-in-treatment-resistant-schizophrenia-122806 https://curecurrent.com/trials/a-tak-831-1001-single-and-multiple-rising-dose-study-in-healthy-participants-122807 https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-spd489-in-adults-with-schizophrenia-and-predominant-negative-symptoms-122808 https://curecurrent.com/trials/exploring-the-effectiveness-of-group-cognitive-stimulation-therapy-in-people-with-schizophrenia-122809 https://curecurrent.com/trials/assess-the-safety-and-pharmacokinetics-of-ascending-multiple-oral-doses-of-spd489-in-adults-with-schizophrenia-122810 https://curecurrent.com/trials/spd489-as-adjunctive-treatment-in-adults-with-negative-symptoms-of-schizophrenia-122811 https://curecurrent.com/trials/effectiveness-of-trauma-therapy-in-patients-with-ptsd-and-comorbid-psychotic-disorder-122812 https://curecurrent.com/trials/cognitive-remediation-program-for-hospitalized-in-the-long-term-patients-with-deficit-schizophrenia-122813 https://curecurrent.com/trials/adjunctive-use-of-fute-flupentixol-in-multi-acting-receptor-targeted-antipsychotics-treated-schizophrenia-patients-122814 https://curecurrent.com/trials/study-to-determine-the-safety-tolerability-and-efficacy-of-evenamide-in-patients-with-chronic-schizophrenia-122815 https://curecurrent.com/trials/improving-negative-symptoms-of-psychosis-in-real-world-environments-122816 https://curecurrent.com/trials/boost-rtms-for-auditory-verbal-hallucinations-122817 https://curecurrent.com/trials/rct-of-tdcs-combined-with-cognitive-training-in-schizophrenia-122818 https://curecurrent.com/trials/familial-schizophrenia-and-spectrum-personality-disorders-122819 https://curecurrent.com/trials/bipolar-and-schizophrenia-consortium-for-parsing-intermediate-phenotypes-122820 https://curecurrent.com/trials/brain-circuits-in-schizophrenia-and-smoking-122821 https://curecurrent.com/trials/bio-equivalence-study-between-saphris-and-asenapine-122822 https://curecurrent.com/trials/pan-european-collaboration-on-antipsychotic-na-ve-schizophrenia-ii-122823 https://curecurrent.com/trials/biological-evaluation-of-dietary-supplement-liposomal-glutathione-122824 https://curecurrent.com/trials/efficacy-and-mechanisms-of-transcranial-direct-current-stimulation-tdcs-effects-on-working-memory-in-schizophrenia-122825 https://curecurrent.com/trials/early-detection-and-intervention-for-women-at-risk-of-psychosis-122826 https://curecurrent.com/trials/effects-of-cannabidiol-on-psychiatric-symptoms-cognition-and-cannabis-consumption-in-cannabis-users-with-recent-onset-ps-122827 https://curecurrent.com/trials/effect-of-intermittent-theta-burst-stimulation-itbs-for-alleviating-symptoms-of-schizophrenia-patients-122828 https://curecurrent.com/trials/body-mind-spirit-intervention-for-women-with-early-psychosis-122829 https://curecurrent.com/trials/peer-support-experience-for-patients-discharged-from-acute-psychiatric-care-122830 https://curecurrent.com/trials/treating-refractory-schizophrenia-with-rtms-122831 https://curecurrent.com/trials/a-single-ascending-dose-study-of-cy150112-after-single-oral-administration-in-healthy-chinese-subjects-122832 https://curecurrent.com/trials/assessing-a-wechat-based-integrative-family-intervention-wifi-for-schizophrenia-122833 https://curecurrent.com/trials/motivational-negative-symptoms-in-schizophrenia-intervention-and-biomarkers-122834 https://curecurrent.com/trials/the-effect-of-psychoeducation-based-on-uncertainty-in-illness-theory-on-schizophrenia-caregivers-122835 https://curecurrent.com/trials/the-appeal-and-impact-of-e-cigarettes-in-smokers-with-smi-122836 https://curecurrent.com/trials/a-safety-tolerability-and-pharmacokinetics-study-of-mk-8189-in-participants-with-schizophrenia-and-in-healthy-participan-122837 https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-and-efficacy-of-switching-from-quetiapine-to-ziprasidone-122838 https://curecurrent.com/trials/safety-and-efficacy-of-ziprasidone-in-adolescents-with-schizophrenia-122839 https://curecurrent.com/trials/extension-study-of-patients-successfully-treated-by-ziprasidone-in-study-a1281031-122840 https://curecurrent.com/trials/side-effects-of-antipsychotic-medications-122841 https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-two-period-cross-over-proof-of-activity-study-to-evaluate-the-effects-of-ta-122842 https://curecurrent.com/trials/phase-1-tak-041-first-in-human-safety-tolerability-and-pharmacokinetics-study-122843 https://curecurrent.com/trials/motive-specific-intervention-for-negative-symptoms-in-schizophrenia-122844 https://curecurrent.com/trials/treatment-of-schizophrenic-patients-with-ziprasidone-122845 https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-for-auditory-hallucinations-in-early-onset-schizophrenia-eos-122846 https://curecurrent.com/trials/extension-study-evaluating-the-safety-of-oral-ziprasidone-in-the-treatment-of-subjects-with-schizophrenia-122847 https://curecurrent.com/trials/safety-and-tolerability-of-ziprasidone-in-adolescents-with-schizophrenia-122848 https://curecurrent.com/trials/one-year-trial-of-oral-ziprasidone-in-patients-with-metabolic-syndrome-122849 https://curecurrent.com/trials/a-randomized-open-label-multi-center-study-to-evaluate-the-efficacy-and-safety-of-intramuscular-ziprasidone-in-patients-122850 https://curecurrent.com/trials/targeting-stress-reactivity-in-schizophrenia-integrated-coping-awareness-therapy-122851 https://curecurrent.com/trials/a-non-interventional-post-marketing-surveillance-study-to-evaluate-the-safety-and-efficacy-of-zeldox-capsule-122852 https://curecurrent.com/trials/5-htr2a-drd2-and-comt-genes-polymorphisms-and-olanzapine-plasma-concentration-in-treatment-of-early-onset-schizophrenia-122853 https://curecurrent.com/trials/lurasidone-effects-on-tissue-glutamate-in-schizophrenia-122854 https://curecurrent.com/trials/brain-imaging-cognitive-enhancement-and-early-schizophrenia-122855 https://curecurrent.com/trials/napls-omega-3-fatty-acid-versus-placebo-study-122856 https://curecurrent.com/trials/clinical-trial-of-bi-425809-effect-on-cognition-and-functional-capacity-in-schizophrenia-122857 https://curecurrent.com/trials/cultivating-well-being-in-severe-psychiatric-conditions-122858 https://curecurrent.com/trials/event-related-potential-erp-biomarkers-in-subjects-with-schizophrenia-and-healthy-volunteer-subjects-122859 https://curecurrent.com/trials/the-outcomes-among-persons-with-schizophrenia-under-the-peer-support-service-in-vocational-rehabilitation-program-122860 https://curecurrent.com/trials/clinical-effect-of-cross-titration-of-antipsychotics-with-ziprasidone-in-schizophrenia-or-schizoaffective-disorder-122861 https://curecurrent.com/trials/effect-and-safety-of-ziprasidone-compared-to-other-atypical-antipsychotic-drug-in-schizophrenic-patients-122862 https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-intramuscular-ziprasidone-followed-by-oral-ziprasidone-for-the-treatment-of-psycho-122863 https://curecurrent.com/trials/a-study-of-the-effects-of-ziprasidone-for-the-treatment-of-schizophrenia-or-schizoaffective-disorder-in-patients-who-wer-122864 https://curecurrent.com/trials/kahn-study-investigation-of-the-efficacy-of-ziprasidone-versus-olanzapine-in-the-management-of-recent-onset-psychosis-a-122865 https://curecurrent.com/trials/12-week-open-non-comparative-switch-study-of-oral-ziprazidone-in-previously-treated-schizophrenic-patients-122866 https://curecurrent.com/trials/a-study-comparing-the-efficacy-and-safety-of-ziprasidone-and-aripiprazole-for-the-treatment-fo-schizophrenia-or-schizoaf-122867 https://curecurrent.com/trials/ziprasidone-pharmacokinetics-using-a-reduced-food-effect-formulation-compared-to-pharmacokinetics-from-commercial-capsul-122868 https://curecurrent.com/trials/a-study-to-compare-the-efficacy-and-safety-of-ziprasidone-and-risperidone-for-the-treatment-of-schizophrenia-in-chinese-122869 https://curecurrent.com/trials/a-study-comparing-the-safety-and-efficacy-of-ziprasidone-and-risperidone-for-the-treatment-of-chronic-schizophrenia-122870 https://curecurrent.com/trials/ziprasidone-versus-olanzapine-in-the-treatment-of-schizophrenia-122871 https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-ziprasidone-in-patients-with-acute-exacerbation-of-schizophrenia-or-schizoaffectiv-122872 https://curecurrent.com/trials/im-and-oral-in-acute-exacerbation-of-schizophrenia-bizet-study-122873 https://curecurrent.com/trials/a-study-of-the-safety-and-tolerability-of-oral-ziprasidone-in-children-and-teens-with-psychotic-disorders-122874 https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-ziprasidone-for-the-treatment-of-acute-exacerbation-of-schizophrenia-or-schizoaffe-122875 https://curecurrent.com/trials/mozart-relapse-study-122876 https://curecurrent.com/trials/non-interventional-study-of-ziprasidone-in-the-treatment-of-bipolar-and-schizoaffective-disorders-122877 https://curecurrent.com/trials/a-study-comparing-the-efficacy-and-tolerability-of-ziprasidone-vs-clozapine-for-the-treatment-of-schizophrenia-in-patien-122878 https://curecurrent.com/trials/cognitive-behavioral-social-skills-training-for-patients-with-late-life-schizophrenia-a-pilot-study-122879 https://curecurrent.com/trials/is-cognitive-training-neuroprotective-in-early-psychosis-122880 https://curecurrent.com/trials/differences-in-schizophrenia-with-one-month-and-3-month-paliperidone-palmitate-treatment-122881 https://curecurrent.com/trials/decision-making-and-decision-support-among-emerging-adults-with-first-episode-psychosis-122882 https://curecurrent.com/trials/goal-management-training-for-patients-with-schizophrenia-or-high-risk-for-schizophrenia-122883 https://curecurrent.com/trials/multi-site-communication-deficits-in-schizophrenia-122884 https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-basmisanil-in-participants-with-cognitive-impairment-associated-with-schizophrenia-ci-122885 https://curecurrent.com/trials/molecular-variants-associated-with-schizophrenia-differential-analysis-of-monozygotic-twins-with-variable-phenotypic-22q-122886 https://curecurrent.com/trials/compensatory-cognitive-training-in-clinical-high-risk-latino-youth-122887 https://curecurrent.com/trials/connectomics-in-psychiatric-classification-of-bipolar-disorder-and-schizophrenia-122888 https://curecurrent.com/trials/expanding-rapid-ascertainment-networks-of-schizophrenia-families-in-taiwan-122889 https://curecurrent.com/trials/salutogenic-approach-based-interview-with-people-with-schizophrenia-122890 https://curecurrent.com/trials/pharmacologic-treatment-of-acute-episode-of-schizophrenia-a-real-world-study-122891 https://curecurrent.com/trials/effectiveness-of-aripiprazole-long-acting-injection-in-recent-onset-and-chronic-schizophrenia-patients-122892 https://curecurrent.com/trials/a-multicenter-open-label-study-investigating-the-pharmacokinetics-and-safety-of-aripiprazole-im-depot-formulation-opc-14-122893 https://curecurrent.com/trials/berberine-as-adjuvant-treatment-for-schizophrenia-patients-122894 https://curecurrent.com/trials/patient-controlled-admissions-in-inpatient-mental-health-services-122895 https://curecurrent.com/trials/biomarkers-in-first-episode-schizophrenia-122896 https://curecurrent.com/trials/safety-blood-levels-and-effects-of-aut00201-122897 https://curecurrent.com/trials/effectiveness-of-using-calligraphic-activity-to-people-with-schizophrenia-122898 https://curecurrent.com/trials/decision-making-capacity-intervention-development-evaluation-in-schizophrenia-spectrum-disorder-122899 https://curecurrent.com/trials/effect-of-hot-footbath-on-the-sleep-quality-122900 https://curecurrent.com/trials/enhancement-of-treatment-of-delusions-in-schizophrenia-through-neuromodulation-122901 https://curecurrent.com/trials/study-of-efficacy-of-pear-004-in-schizophrenia-122902 https://curecurrent.com/trials/aripiprazole-im-depot-for-chinese-patients-with-schizophrenia-122903 https://curecurrent.com/trials/aripiprazole-im-depot-in-the-acute-treatment-of-adults-with-schizophrenia-122904 https://curecurrent.com/trials/pharmacodynamic-pharmacokinetic-study-of-aqw051-in-schizophrenia-122905 https://curecurrent.com/trials/effect-of-aqw051-on-cognitive-function-in-patients-with-chronic-stable-schizophrenia-122906 https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-once-daily-doses-of-aqw051-on-cognition-in-stable-schizophrenia-patients-122907 https://curecurrent.com/trials/efficacy-and-safety-of-pimavanserin-as-adjunctive-treatment-for-the-negative-symptoms-of-schizophrenia-advance-122908 https://curecurrent.com/trials/efficacy-study-of-galantamine-for-cognitive-impairments-in-schizophrenia-122909 https://curecurrent.com/trials/searching-for-early-biomarkers-of-long-term-hepatic-metabolic-and-endothelial-dysfunction-in-non-affective-psychosis-122910 https://curecurrent.com/trials/longitudinal-long-term-study-10-years-of-the-sample-of-first-episode-of-non-affective-psychosis-pafip-122911 https://curecurrent.com/trials/quetiapine-and-the-dopaminergic-epigenetic-control-122912 https://curecurrent.com/trials/personalizing-interventions-using-real-world-interactions-122913 https://curecurrent.com/trials/safety-and-tolerability-of-single-and-multiple-doses-of-lb-102-in-healthy-adults-122914 https://curecurrent.com/trials/comparison-of-a-long-acting-injectable-antipsychotic-vs-clinician-s-choice-early-in-treatment-to-break-the-cycle-of-rela-122915 https://curecurrent.com/trials/prefrontal-cortical-engagement-through-non-invasive-brain-stimulation-in-schizophrenia-122916 https://curecurrent.com/trials/antipsychotic-induced-structural-and-functional-brain-changes-122917 https://curecurrent.com/trials/brain-imaging-in-early-psychosis-122918 https://curecurrent.com/trials/effects-of-online-and-recovery-oriented-peer-support-groups-facilitated-by-peer-support-workers-in-times-of-covid-19-122919 https://curecurrent.com/trials/pharmacogenomic-decision-support-with-genesight-psychotropic-to-guide-the-treatment-with-antipsychotics-122920 https://curecurrent.com/trials/level-of-immersion-of-virtual-reality-and-cognition-and-motor-performance-in-patients-of-schizophrenia-spectrum-disorder-122921 https://curecurrent.com/trials/cognitive-factors-mediating-the-relationship-between-childhood-trauma-and-auditory-hallucinations-in-schizophrenia-122922 https://curecurrent.com/trials/stage-specific-case-management-for-early-psychosis-122923 https://curecurrent.com/trials/evaluate-the-pk-of-ly03010-process-1-and-process-2-drug-product-vs-invega-sustenna-after-intramuscular-injection-in-schi-122924 https://curecurrent.com/trials/linagliptin-and-mesenchymal-stem-cells-a-pilot-study-122925 https://curecurrent.com/trials/good-shepherd-back-to-reality-series-122926 https://curecurrent.com/trials/the-application-of-wearable-technology-to-improve-the-physical-activity-level-of-people-with-chronic-mental-illness-122927 https://curecurrent.com/trials/phase-iv-to-evaluate-the-safety-of-self-administered-adasuve-in-agitated-patients-outside-the-hospital-setting-122928 https://curecurrent.com/trials/bilateral-repetitive-transcranial-magnetic-stimulation-for-auditory-hallucinations-results-122929 https://curecurrent.com/trials/a-study-to-assess-safety-and-efficacy-of-karxt-in-adult-patients-with-schizophrenia-122930 https://curecurrent.com/trials/the-use-of-transcranial-electrical-stimulation-for-hallucinations-122931 https://curecurrent.com/trials/flexible-dose-long-term-safety-study-of-lu-af35700-in-adult-patients-with-schizophrenia-122932 https://curecurrent.com/trials/validation-of-a-tool-for-the-dimensional-assessment-of-apathy-in-a-population-suffering-from-schizophrenia-122933 https://curecurrent.com/trials/early-diagnosis-of-intracranial-infection-after-craniotomy-122934 https://curecurrent.com/trials/study-to-assess-efficacy-and-safety-of-hp3070-in-subjects-diagnosed-with-schizophrenia-122935 https://curecurrent.com/trials/comparison-of-e-health-vs-in-person-multi-family-group-mfg-122936 https://curecurrent.com/trials/simvastatin-addition-for-patients-with-recent-onset-schizophrenia-122937 https://curecurrent.com/trials/nicotine-and-sensorimotor-replacement-for-smoking-in-smokers-with-schizophrenia-122938 https://curecurrent.com/trials/double-blind-placebo-controlled-randomised-investigation-of-ondansetron-in-schizophrenia-122939 https://curecurrent.com/trials/psychological-therapy-for-dissociation-trauma-and-voices-a-single-case-experimental-design-122940 https://curecurrent.com/trials/convergent-and-concurrent-validity-between-clinical-recovery-and-personal-civic-recovery-in-mental-health-122941 https://curecurrent.com/trials/d-serine-and-cognitive-remediation-in-schizophrenia-122942 https://curecurrent.com/trials/brain-activation-patterns-in-schizophrenia-after-computerized-cognitive-skills-training-122943 https://curecurrent.com/trials/safety-and-effectiveness-of-d-serine-in-schizophrenia-122944 https://curecurrent.com/trials/cognitive-remediation-therapy-for-participants-with-late-life-schizophrenia-122945 https://curecurrent.com/trials/diagnostic-announcement-to-relatives-of-patients-with-schizophrenia-122946 https://curecurrent.com/trials/nurse-led-psycho-education-program-for-people-with-first-onset-mental-illness-apn-pep-122947 https://curecurrent.com/trials/treating-cognition-in-schizophrenia-with-atomoxetine-and-cognitive-remediation-122948 https://curecurrent.com/trials/mindfulness-group-based-intervention-for-early-psychosis-122949 https://curecurrent.com/trials/a-long-term-study-of-clozapine-in-patients-with-treatment-resistant-schizophrenia-122950 https://curecurrent.com/trials/study-with-lu-af11167-for-the-treatment-of-negative-symptoms-in-patients-with-schizophrenia-122951 https://curecurrent.com/trials/flexible-dose-long-term-extension-study-of-lu-af11167-in-patients-with-schizophrenia-with-prominent-negative-symptoms-122952 https://curecurrent.com/trials/theta-tacs-during-working-memory-training-a-pilot-study-of-the-effects-on-negative-symptoms-of-schizophrenia-122953 https://curecurrent.com/trials/targeting-physical-health-in-schizophrenia-physical-activity-can-enhance-life-122954 https://curecurrent.com/trials/bilateral-repetitive-transcranial-magnetic-stimulation-for-auditory-hallucinations-original-study-122955 https://curecurrent.com/trials/assessing-the-effect-of-compensatory-cognitive-intervention-among-people-with-severe-mental-illness-122956 https://curecurrent.com/trials/effectiveness-of-a-cardiovascular-risk-intervention-program-in-patients-with-schizophrenia-prisca-122957 https://curecurrent.com/trials/ect-in-ultra-resistant-schizophrenia-122958 https://curecurrent.com/trials/problem-solving-based-bibliotherapy-program-for-family-caregivers-122959 https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-of-glial-activation-in-psychotic-disease-states-122960 https://curecurrent.com/trials/a-problem-solving-based-bibliotherapy-program-for-family-caregivers-in-schizophrenia-122961 https://curecurrent.com/trials/exploring-the-effects-of-a-baduanjin-program-on-the-symptoms-of-constipation-in-patients-with-schizophrenia-spectrum-122962 https://curecurrent.com/trials/effectiveness-of-a-nurse-facilitated-face-care-group-in-patients-with-schizophrenia-122963 https://curecurrent.com/trials/phosphatidylcholine-supplementation-in-infants-122964 https://curecurrent.com/trials/trial-to-assess-the-bioavailability-of-quetiapine-versus-seroquel-in-subjects-with-schizophrenia-or-bipolar-disorder-122965 https://curecurrent.com/trials/brain-stimulation-and-cognitive-training-122967 https://curecurrent.com/trials/european-long-acting-antipsychotics-in-schizophrenia-trial-122968 https://curecurrent.com/trials/study-on-the-gut-microbial-mechanism-of-negative-symptoms-of-schizophrenia-122969 https://curecurrent.com/trials/study-on-examination-of-therapeutic-efficacy-and-potential-mechanisms-of-yoga-treatment-in-schizophrenia-122970 https://curecurrent.com/trials/smart-design-to-compare-antipsychotic-treatments-in-treatment-resistant-schizophrenia-122971 https://curecurrent.com/trials/atypical-antipsychotics-influence-on-the-safety-of-the-heart-and-monitoring-indicators-model-building-122972 https://curecurrent.com/trials/cognitive-and-emotional-factors-in-visual-exploration-among-patients-with-schizophrenia-122973 https://curecurrent.com/trials/prediction-of-violent-behavior-in-patients-with-schizophrenia-by-multimodal-machine-learning-122974 https://curecurrent.com/trials/effects-of-narrative-enhancement-and-cognitive-therapy-nect-on-self-stigma-in-patients-with-schizophrenia-122975 https://curecurrent.com/trials/research-on-accurate-prediction-of-long-term-medication-use-for-schizophrenia-based-on-cognitive-function-122976 https://curecurrent.com/trials/comparing-cognitive-remediation-approaches-for-schizophrenia-122977 https://curecurrent.com/trials/the-effectiveness-of-assertive-community-treatment-on-schizophrenic-patients-122978 https://curecurrent.com/trials/a-study-of-aripiprazole-lauroxil-or-paliperidone-palmitate-for-the-treatment-of-schizophrenia-122979 https://curecurrent.com/trials/rtms-on-mismatch-negativity-of-schizophrenia-122980 https://curecurrent.com/trials/substance-misuse-to-psychosis-for-ketamine-stop-k-122981 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-aut00206-in-patients-with-schizophrenia-and-also-explores-the-effects-of-aut-122982 https://curecurrent.com/trials/best-event-schizophrenia-trial-a-randomized-double-blind-trial-of-aripiprazole-and-risperidone-in-schizophrenia-122983 https://curecurrent.com/trials/thinking-skills-at-work-cognitive-remediation-therapy-for-patients-with-serious-mental-illness-122984 https://curecurrent.com/trials/occupational-recovery-after-first-episode-psychosis-122985 https://curecurrent.com/trials/implementation-and-evaluation-of-a-family-based-intervention-program-for-children-of-mentally-ill-parents-122986 https://curecurrent.com/trials/animal-assisted-therapy-in-patients-with-schizophrenia-122987 https://curecurrent.com/trials/avatar-therapy-in-comparison-to-cognitive-behavioral-therapy-for-treatment-resistant-schizophrenia-122988 https://curecurrent.com/trials/a-trial-to-explore-acceptance-and-performance-of-using-a-digital-medicine-system-with-healthcare-professionals-and-adult-122989 https://curecurrent.com/trials/technology-enabled-collaborative-care-for-youth-122990 https://curecurrent.com/trials/pk-study-of-aripiprazole-im-depot-for-chinese-patients-with-schizophrenia-122991 https://curecurrent.com/trials/a-study-in-italy-about-evidence-based-psychosocial-rehabilitative-interventions-in-patients-with-early-schizophrenia-tre-122992 https://curecurrent.com/trials/electroencephalogram-eeg-and-electroconvulsive-therapy-ect-response-in-schizophrenia-122993 https://curecurrent.com/trials/effect-of-vortioxetine-on-cognitive-symptoms-in-patients-with-schizophrenia-122994 https://curecurrent.com/trials/critical-time-intervention-task-shifting-randomized-controlled-trial-122995 https://curecurrent.com/trials/magnetic-seizure-therapy-mst-for-treatment-resistant-depression-schizophrenia-and-obsessive-compulsive-disorder-122996 https://curecurrent.com/trials/bergen-psychosis-project-2-the-best-intro-study-122997 https://curecurrent.com/trials/representations-and-strategies-for-recovery-122998 https://curecurrent.com/trials/efficacy-and-safety-of-adjunctive-pimavanserin-for-the-treatment-of-schizophrenia-enhance-1-122999 https://curecurrent.com/trials/effectiveness-of-the-individualized-metacognitive-training-emc-in-people-with-psychosis-of-brief-evolution-123000 https://curecurrent.com/trials/lifestyle-redesign-for-schizophrenia-123001 https://curecurrent.com/trials/hormonal-and-inflammatory-biomarkers-and-response-to-cognitive-remediation-in-recent-onset-psychosis-123002 https://curecurrent.com/trials/feasibility-and-outcomes-of-a-digital-health-support-for-the-schizophrenia-spectrum-123003 https://curecurrent.com/trials/effects-of-12-weeks-walking-on-cognitive-function-in-schizophrenia-123004 https://curecurrent.com/trials/pet-imaging-study-of-amish-and-mennonite-patients-with-cntnap2-mutations-123005 https://curecurrent.com/trials/impact-of-stigma-in-siblings-of-young-patients-with-schizophrenic-disorders-123006 https://curecurrent.com/trials/imaging-dopamine-d2-agonist-binding-sites-in-schizophrenia-123007 https://curecurrent.com/trials/maternal-adversity-vulnerability-and-neurodevelopment-123008 https://curecurrent.com/trials/estradiol-as-add-on-to-antipsychotics-123009 https://curecurrent.com/trials/estradiol-patch-as-add-on-to-antipsychotics-in-patients-with-schizophrenia-schizoaffective-or-schizophreniform-disorder-123010 https://curecurrent.com/trials/effect-evaluation-of-individual-placement-and-support-ips-123011 https://curecurrent.com/trials/positron-emission-tomography-pet-study-investigating-dopamine-and-serotonin-receptor-occupancy-after-multiple-oral-dosin-123012 https://curecurrent.com/trials/transcranial-direct-current-stimulation-and-effects-on-early-auditory-processing-in-schizophrenia-123013 https://curecurrent.com/trials/using-short-message-service-as-a-means-of-clinical-engagement-in-early-psychosis-123014 https://curecurrent.com/trials/a-study-to-determine-the-maximum-tolerated-dose-of-an-investigational-drug-in-subjects-with-schizophrenia-123015 https://curecurrent.com/trials/target-engagement-of-the-early-auditory-processing-network-by-transcranial-direct-current-stimulation-tdcs-123016 https://curecurrent.com/trials/brief-group-psychoeducation-for-schizophrenia-123017 https://curecurrent.com/trials/clozapine-for-cannabis-use-in-schizophrenia-123018 https://curecurrent.com/trials/the-clinical-and-socio-demographic-characteristics-of-young-people-aged-12-to-25-consulting-on-ambulatory-structures-in-123019 https://curecurrent.com/trials/efficacy-and-tolerability-of-switching-to-ziprasidone-from-other-antipsychotics-123020 https://curecurrent.com/trials/oral-status-of-patients-suffering-from-schizophrenia-followed-at-charles-perrens-hospital-123021 https://curecurrent.com/trials/magnetic-stimulation-of-the-brain-in-schizophrenia-or-depression-123022 https://curecurrent.com/trials/antipsychotic-effects-on-brain-function-in-schizophrenia-123023 https://curecurrent.com/trials/cognitive-remediation-program-for-family-caregivers-in-schizophrenia-123024 https://curecurrent.com/trials/adapted-cognitive-affective-remediation-for-cannabis-misuse-in-schizophrenia-123025 https://curecurrent.com/trials/aripiprazole-abilify-maintena-collaborative-clinical-protocol-123026 https://curecurrent.com/trials/evaluating-a-new-iloperidone-titration-scheme-in-bipolar-i-disorder-or-schizophrenia-123027 https://curecurrent.com/trials/efficacy-of-metacognitive-training-for-schizophrenia-a-study-protocol-123028 https://curecurrent.com/trials/survey-on-pre-ect-evaluation-and-ect-application-123029 https://curecurrent.com/trials/alcohol-use-disorders-in-schizophrenia-123030 https://curecurrent.com/trials/influence-of-vitamin-d-supplementation-on-serum-bdnf-level-and-cognitive-function-in-schizophrenia-123031 https://curecurrent.com/trials/culturally-responsive-person-centered-care-for-psychosis-123032 https://curecurrent.com/trials/glycine-vs-placebo-for-the-schizophrenia-prodrome-123033 https://curecurrent.com/trials/transcranial-magnetic-stimulation-for-voices-123034 https://curecurrent.com/trials/lurasidone-vs-olanzapine-on-neurotrophic-biomarkers-and-cardiometabolic-parameters-in-unmedicated-schizophrenia-123035 https://curecurrent.com/trials/treatment-with-acamprosate-in-patients-with-schizophrenia-and-comorbid-alcoholism-123036 https://curecurrent.com/trials/cognitive-training-and-enhanced-supported-employment-in-schizophrenia-123037 https://curecurrent.com/trials/benefits-management-for-people-with-psychiatric-disabilities-123038 https://curecurrent.com/trials/endocannabinoid-control-of-microglia-activation-as-a-new-therapeutic-target-in-the-treatment-of-schizophrenia-123039 https://curecurrent.com/trials/the-effect-of-sertindole-and-risperidone-on-endophenotypic-markers-of-schizophrenia-123040 https://curecurrent.com/trials/psychosocial-therapy-and-risperidone-treatment-in-work-performance-in-recent-onset-schizophrenia-123041 https://curecurrent.com/trials/d-cycloserine-augmentation-of-cognitive-behavioral-therapy-for-delusions-123042 https://curecurrent.com/trials/family-focused-therapy-for-youth-with-early-onset-bipolar-or-psychotic-disorders-123043 https://curecurrent.com/trials/a-6-month-study-to-evaluate-sulforaphane-add-on-effects-in-treatment-of-schizophrenia-123044 https://curecurrent.com/trials/tdcs-for-auditory-hallucinations-in-schizophrenia-123045 https://curecurrent.com/trials/virtual-reality-training-for-social-skills-in-schizophrenia-123046 https://curecurrent.com/trials/using-clinical-process-indicators-patient-reported-outcome-measures-proms-and-patient-reported-experience-measures-prems-123047 https://curecurrent.com/trials/psychopathological-differences-between-asperger-syndrome-and-schizotypal-disorder-in-an-adult-sample-123048 https://curecurrent.com/trials/efficacy-and-mechanisms-of-change-of-an-emotion-oriented-version-of-cognitive-behavioral-therapy-for-psychosis-123049 https://curecurrent.com/trials/phenomics-and-genomics-of-clozapine-pharmacotherapy-123050 https://curecurrent.com/trials/pilot-trial-of-emotion-focused-cognitive-behavior-therapy-for-patients-with-schizophrenia-123051 https://curecurrent.com/trials/can-cognitive-training-decrease-reactive-aggression-123052 https://curecurrent.com/trials/pact-for-individuals-with-serious-mental-illness-123053 https://curecurrent.com/trials/adult-study-oxytocin-behavioral-123054 https://curecurrent.com/trials/tracking-outcomes-in-psychosis-123055 https://curecurrent.com/trials/psychoeducation-in-patients-who-diagnosed-with-schizophrenia-123056 https://curecurrent.com/trials/texting-for-relapse-prevention-123057 https://curecurrent.com/trials/the-evaluation-of-the-use-of-a-new-physical-health-plan-123058 https://curecurrent.com/trials/the-effect-of-long-acting-antipsychotics-on-schizophrenia-patients-with-violence-risk-123059 https://curecurrent.com/trials/cognitive-remediation-therapy-in-schizophrenia-effects-on-epigenetics-123060 https://curecurrent.com/trials/deep-brain-stimulation-in-treatment-resistant-schizophrenia-123061 https://curecurrent.com/trials/safety-and-tolerability-of-risperidone-implants-123062 https://curecurrent.com/trials/expanded-game-squad-for-neurodiverse-youth-123063 https://curecurrent.com/trials/study-in-stabilized-schizophrenic-patients-to-evaluate-the-pharmacokinetics-of-risperidone-and-9-hydroxy-oh-risperidone-123064 https://curecurrent.com/trials/the-street-smart-group-a-feasibility-trial-of-a-group-intervention-targeting-anxiety-processes-in-paranoia-123065 https://curecurrent.com/trials/efficacy-of-transcranial-direct-current-stimulation-in-treatment-of-cognitive-deficits-in-early-stages-of-psychosis-123066 https://curecurrent.com/trials/perception-processing-in-schizophrenia-patients-and-normal-population-123067 https://curecurrent.com/trials/neurophysiological-evaluation-of-schizophrenia-patients-after-cognitive-and-physical-intervention-123068 https://curecurrent.com/trials/study-of-the-activation-of-proinflammatory-pathways-of-toll-like-receptors-in-schizophrenia-patients-123069 https://curecurrent.com/trials/prepulse-inhibition-ppi-of-startle-reflex-in-schizophrenia-patients-related-to-type-of-treatment-and-illness-duration-123070 https://curecurrent.com/trials/effectiveness-of-second-generation-antipsychotics-in-first-episode-psychosis-patients-1-year-follow-up-123071 https://curecurrent.com/trials/assessment-of-the-effectiveness-of-the-nect-program-123072 https://curecurrent.com/trials/modulating-human-cortical-plasticity-with-transcranial-electrical-stimulation-123073 https://curecurrent.com/trials/a-study-of-alks-3831-in-adults-with-schizophrenia-the-enlighten-2-study-123074 https://curecurrent.com/trials/dopamine-d2-and-d3-receptor-occupancy-and-clinical-response-in-older-patients-with-schizophrenia-123075 https://curecurrent.com/trials/hope-team-clinical-high-risk-group-cbsst-123076 https://curecurrent.com/trials/evaluating-a-novel-mobile-app-for-social-cognition-in-psychosis-123077 https://curecurrent.com/trials/prospective-studies-of-the-pathogenesis-of-schizophrenia-123078 https://curecurrent.com/trials/a-study-of-lurasidone-hcl-in-subjects-with-schizophrenia-123079 https://curecurrent.com/trials/the-relevance-between-the-microrna-30e-in-plasma-and-the-prognosis-of-schizophrenia-patients-123080 https://curecurrent.com/trials/phase-2-trial-of-a-nicotinic-agonist-in-schizophrenia-123081 https://curecurrent.com/trials/clinical-and-genetic-influencing-factors-on-clozapine-pharmacokinetics-123082 https://curecurrent.com/trials/action-based-cognitive-remediation-for-first-episode-psychosis-123083 https://curecurrent.com/trials/effect-of-metacognitive-therapy-on-negative-symptoms-a-case-series-123084 https://curecurrent.com/trials/multi-dimensional-investigations-of-negative-emotions-and-drug-resistant-auditory-verbal-hallucinations-in-psychosis-123085 https://curecurrent.com/trials/enhancing-motivation-in-recent-onset-schizophrenia-123086 https://curecurrent.com/trials/efficacy-of-lu-af35700-in-patients-with-early-in-disease-or-late-in-disease-treatment-resistant-schizophrenia-123087 https://curecurrent.com/trials/novel-candidate-genes-for-treatment-response-to-antipsychotics-in-schizophrenia-123088 https://curecurrent.com/trials/neurocognitive-effectiveness-in-treatment-of-first-episode-non-affective-psychosis-3-years-follow-up-123089 https://curecurrent.com/trials/cost-effectiveness-of-interventions-in-first-episode-psychosis-123090 https://curecurrent.com/trials/10-year-follow-up-of-clinical-outcome-after-antipsychotic-treatment-discontinuation-in-psychosis-individuals-123091 https://curecurrent.com/trials/effects-of-transcranial-direct-current-stimulation-tdcs-on-persistent-auditory-verbal-hallucinations-in-schizophrenia-123092 https://curecurrent.com/trials/efficacy-of-social-cognitive-training-sct-in-recent-onset-psychosis-123093 https://curecurrent.com/trials/symptom-based-treatment-affects-brain-plasticity-the-role-of-verbal-auditory-hallucinations-123094 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-pf-04958242-in-subjects-with-cognitive-impairment-associated-with-schizop-123095 https://curecurrent.com/trials/selective-estrogen-receptor-modulators-for-women-of-child-bearing-age-with-schizophrenia-123096 https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-single-doses-of-pf-04958242-in-healthy-volunteers-123097 https://curecurrent.com/trials/an-open-label-multicenter-rollover-long-term-study-of-aripiprazole-intramuscular-depot-in-participants-with-schizophreni-123098 https://curecurrent.com/trials/a-long-term-trial-of-opc-34712-in-patients-with-schizophrenia-123099 https://curecurrent.com/trials/shared-decision-making-in-psychiatric-inpatient-care-123100 https://curecurrent.com/trials/pediatric-open-label-extension-study-123101 https://curecurrent.com/trials/vitamin-b6-and-b12-in-the-treatment-of-movement-disorders-induced-by-antipsychotics-123102 https://curecurrent.com/trials/mindfulness-based-illness-management-program-for-schizophrenia-123103 https://curecurrent.com/trials/decifer-depression-and-citalopram-in-first-episode-recovery-123104 https://curecurrent.com/trials/electrophysiology-and-blood-flow-in-patients-with-schizophrenia-and-their-siblings-123105 https://curecurrent.com/trials/magnetic-resonance-imaging-mri-of-neuropsychiatric-patients-and-healthy-volunteers-123106 https://curecurrent.com/trials/influence-of-nicotine-on-cognitive-function-in-schizophrenic-patients-with-and-without-comorbid-drug-dependence-123107 https://curecurrent.com/trials/transcranial-direct-current-brain-stimulation-to-treat-patients-with-childhood-onset-schizophrenia-123108 https://curecurrent.com/trials/assessment-of-craving-in-nicotine-dependent-patients-with-schizophrenia-using-virtual-reality-123109 https://curecurrent.com/trials/symptom-based-treatment-affects-brain-plasticity-cognitive-training-in-patients-with-affective-symptoms-123110 https://curecurrent.com/trials/treatment-of-refractory-schizophrenia-with-riluzole-123111 https://curecurrent.com/trials/dopamine-function-and-reward-processing-in-schizophrenia-123112 https://curecurrent.com/trials/effects-of-modafinil-on-brain-function-in-patients-with-schizophrenia-123113 https://curecurrent.com/trials/brain-tissue-collection-for-neuropathological-studies-123114 https://curecurrent.com/trials/open-label-study-of-the-efficacy-of-intranasal-oxytocin-in-schizophrenia-123115 https://curecurrent.com/trials/a-concierge-model-of-cae-plus-lai-in-individuals-with-schizophrenia-at-risk-for-treatment-non-adherence-and-homelessness-123116 https://curecurrent.com/trials/effect-of-intranasal-vasopressin-on-cooperative-behavior-in-schizophrenia-123117 https://curecurrent.com/trials/vr-therapy-for-psychosis-negative-symptoms-v-nest-123118 https://curecurrent.com/trials/efficacy-of-equine-assisted-therapy-on-negative-symptoms-in-patients-with-schizophrenia-123119 https://curecurrent.com/trials/improving-cognition-in-schizophrenia-using-non-invasive-brain-stimulation-123120 https://curecurrent.com/trials/perinatal-mental-health-care-in-switzerland-123121 https://curecurrent.com/trials/theta-burst-stimulation-for-schizophrenia-123122 https://curecurrent.com/trials/effect-of-lu-af35700-in-patients-with-treatment-resistant-schizophrenia-123123 https://curecurrent.com/trials/metyrosine-demser-for-the-treatment-of-psychotic-disorders-in-patients-with-velocardiofacial-syndrome-123124 https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-rtms-self-referential-processing-rtms-srp-123125 https://curecurrent.com/trials/study-of-the-pf-04958242-blood-concentrations-of-a-capsule-formulation-of-pf-04958242-compared-to-a-solution-formulation-123126 https://curecurrent.com/trials/a-study-to-examine-the-effects-of-pf-04958242-on-ketamine-induced-cognitive-impairment-in-healthy-volunteers-123127 https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-repeated-doses-of-pf-04958242-in-healthy-volunteers-123128 https://curecurrent.com/trials/a-study-to-examine-the-safety-tolerability-and-pharmacokinetics-of-pf-04958242-in-psychiatrically-stable-subjects-with-s-123129 https://curecurrent.com/trials/the-family-voice-study-123130 https://curecurrent.com/trials/antipsychotic-effects-of-oxytocin-123131 https://curecurrent.com/trials/a-clinical-trial-of-lurasidone-in-treatment-of-schizophrenia-123132 https://curecurrent.com/trials/neurobiological-effects-of-oxytocin-in-schizophrenia-imaging-study-123133 https://curecurrent.com/trials/a-study-of-staccato-loxapine-adasuve-for-inhalation-123134 https://curecurrent.com/trials/reducing-cardiovascular-risk-in-adults-with-serious-mental-illness-123135 https://curecurrent.com/trials/clinical-trial-of-dipyridamole-in-schizophrenia-123136 https://curecurrent.com/trials/application-of-a-mindfulness-and-self-compassion-program-in-patients-with-schizophrenia-randomized-controlled-trial-123137 https://curecurrent.com/trials/knowledge-and-perception-of-smoking-risks-consequences-123138 https://curecurrent.com/trials/efficiency-of-the-french-translation-social-cognition-and-interactive-training-scit-program-123139 https://curecurrent.com/trials/aerobic-exercise-for-cognition-in-schizophrenia-123140 https://curecurrent.com/trials/efficiency-of-art-therapy-in-psychotic-disorders-123141 https://curecurrent.com/trials/anatomical-and-structural-connectivity-in-two-psychotic-phenotypes-periodic-catatonia-and-cataphasia-123142 https://curecurrent.com/trials/art-therapy-in-acute-psychiatry-123143 https://curecurrent.com/trials/long-term-exercise-training-therapy-versus-usual-care-in-patients-with-schizophrenia-123144 https://curecurrent.com/trials/a-dose-finding-trial-of-opc-34712-in-patients-with-schizophrenia-123145 https://curecurrent.com/trials/oxytocin-and-social-cognition-in-schizophrenia-123146 https://curecurrent.com/trials/quantitative-investigation-of-environment-and-participation-123147 https://curecurrent.com/trials/metacognitive-training-and-insight-in-schizophrenia-123148 https://curecurrent.com/trials/risperidone-treatment-in-schizophrenia-patients-who-are-currently-taking-clozapine-123149 https://curecurrent.com/trials/double-blind-placebo-controlled-study-of-adjunctive-aripiprazole-for-symptomatic-hyperprolactinemia-in-premenopausal-wom-123150 https://curecurrent.com/trials/neuroendocrine-and-immune-response-to-stress-in-schizophrenia-123151 https://curecurrent.com/trials/gluten-free-diet-in-people-with-schizophrenia-a-pilot-study-123152 https://curecurrent.com/trials/randomized-controlled-trial-of-a-gluten-free-diet-in-patients-with-schizophrenia-who-are-gliadin-positive-123153 https://curecurrent.com/trials/multimodal-physical-therapy-program-in-schizophrenia-123154 https://curecurrent.com/trials/homeless-youth-study-stepping-stone-2-0-123155 https://curecurrent.com/trials/intracellular-tight-junction-permeability-in-schizophrenia-focus-on-zonulin-123156 https://curecurrent.com/trials/treatment-of-social-cognition-in-schizophrenia-trial-123157 https://curecurrent.com/trials/tobacco-craving-and-triggers-in-persons-with-schizophrenia-123158 https://curecurrent.com/trials/biomarker-study-of-acamprosate-in-schizophrenia-123159 https://curecurrent.com/trials/oxytocin-add-on-study-for-stable-schizophrenic-patients-123160 https://curecurrent.com/trials/18-fluorine-f-dopa-determinants-and-predictors-of-treatment-response-in-psychosis-123161 https://curecurrent.com/trials/rasagiline-in-the-treatment-of-persistent-negative-symptoms-of-schizophrenia-123162 https://curecurrent.com/trials/oxytocin-and-cbsst-for-people-with-schizophrenia-123163 https://curecurrent.com/trials/therapeutic-drug-monitoring-for-individualized-clozapine-therapy-123164 https://curecurrent.com/trials/predicting-antipsychotic-discontinuation-in-psychosis-123165 https://curecurrent.com/trials/benefits-of-physical-exercise-in-schizophrenia-123166 https://curecurrent.com/trials/effects-of-hyperprolactinemia-induced-by-antipsychotic-drugs-on-bone-metabolism-123167 https://curecurrent.com/trials/psychosis-and-affective-research-domains-and-intermediate-phenotypes-123168 https://curecurrent.com/trials/the-imaging-genetic-study-of-schizophrenia-and-family-123169 https://curecurrent.com/trials/community-based-cognitive-training-in-early-schizophrenia-123170 https://curecurrent.com/trials/role-of-antioxidants-vitamin-c-and-e-in-the-management-of-schizophrenia-123171 https://curecurrent.com/trials/effects-of-neurocognitive-and-social-cognitive-remediation-in-patients-at-ultra-high-risk-of-psychosis-123172 https://curecurrent.com/trials/nicotinic-enhancement-of-cognitive-remediation-training-in-schizophrenia-123173 https://curecurrent.com/trials/study-investigating-the-effect-of-lu-af35700-on-cardiac-repolarization-in-men-and-women-with-schizophrenia-and-schizoaff-123174 https://curecurrent.com/trials/evaluation-the-impact-of-self-stigma-reduction-program-on-psychosocial-outcomes-among-people-diagnosed-with-schizophreni-123175 https://curecurrent.com/trials/patient-s-preference-between-conventional-oral-olanzapine-tablet-vs-olanzapine-orodispersible-tablet-123176 https://curecurrent.com/trials/virtual-rehabilitation-for-the-treatment-of-motivational-deficits-in-schizophrenia-123177 https://curecurrent.com/trials/effects-of-oxytocin-nasal-spray-on-social-affiliation-123178 https://curecurrent.com/trials/adjunctive-selective-estrogen-receptor-modulators-on-negative-and-cognitive-symptoms-of-schizophrenia-in-women-123179 https://curecurrent.com/trials/have-a-good-grasp-of-the-worldthe-world-123180 https://curecurrent.com/trials/oxytocin-as-adjunctive-treatment-of-schizophrenia-123181 https://curecurrent.com/trials/the-treatment-efficacy-of-combination-atypical-antipsychotics-with-sertraline-in-patients-with-schizophrenia-123182 https://curecurrent.com/trials/anti-inflammatories-and-adolescent-schizophrenia-123183 https://curecurrent.com/trials/a-research-in-pharmacogenomics-and-accurate-medication-of-risperidone-123184 https://curecurrent.com/trials/antipsychotics-and-blood-vessel-function-123185 https://curecurrent.com/trials/medactive-a-smartphone-intervention-to-improve-adherence-to-antipsychotic-medications-123186 https://curecurrent.com/trials/adjunctive-minocycline-in-clozapine-treated-schizophrenia-patients-123187 https://curecurrent.com/trials/effects-of-intranasal-oxytocin-on-satiety-signaling-in-people-with-schizophrenia-123188 https://curecurrent.com/trials/exploring-the-effect-of-baduanjin-on-the-metabolic-parameters-and-body-mass-index-of-people-with-schizophrenia-123189 https://curecurrent.com/trials/a-study-of-cariprazine-in-patients-with-chronic-stable-schizophrenia-123190 https://curecurrent.com/trials/adjunctive-treatment-for-decreasing-symptoms-of-schizophrenia-123191 https://curecurrent.com/trials/screening-protocol-for-research-participants-123192 https://curecurrent.com/trials/new-antipsychotic-strategies-quetiapine-and-risperidone-vs-fluphenazine-in-treatment-resistant-schizophrenia-123193 https://curecurrent.com/trials/effects-of-smoking-cues-on-tobacco-craving-responses-and-the-reinforcing-efficacy-of-cigarettes-in-smokers-with-and-with-123194 https://curecurrent.com/trials/atomoxetine-as-an-adjunct-to-novel-antipsychotic-medication-in-the-treatment-of-cognitive-deficits-of-schizophrenia-123195 https://curecurrent.com/trials/brain-blood-flow-changes-elicited-by-oxytocin-in-volunteers-with-and-without-schizophrenia-123196 https://curecurrent.com/trials/schizophrenia-and-the-gut-microbiome-123197 https://curecurrent.com/trials/music-to-reduce-use-of-smoking-in-patients-with-schizophrenia-123198 https://curecurrent.com/trials/evaluating-two-types-of-cognitive-training-in-veterans-with-schizophrenia-123199 https://curecurrent.com/trials/the-role-of-nitric-oxide-in-cognition-in-schizophrenia-123200 https://curecurrent.com/trials/a-study-to-determine-pharmacokinetic-characteristics-of-ly03010-versus-invega-sustenna-in-schizophrenia-patients-123201 https://curecurrent.com/trials/real-time-mobile-cognitive-behavioral-intervention-for-serious-mental-illness-123202 https://curecurrent.com/trials/measuring-beliefs-and-norms-about-persons-with-mental-illness-123203 https://curecurrent.com/trials/validating-and-optimizing-model-of-antipsychotics-selection-123204 https://curecurrent.com/trials/sensorimotor-gating-in-schizophrenia-123205 https://curecurrent.com/trials/anticonvulsant-mood-stabilizers-antipsychotic-drugs-and-the-insulin-resistance-syndrome-123206 https://curecurrent.com/trials/role-of-anti-inflammatory-agents-in-patients-with-schizophrenia-123207 https://curecurrent.com/trials/minocycline-and-or-omega-3-fatty-acids-added-to-treatment-as-usual-for-at-risk-mental-states-123208 https://curecurrent.com/trials/the-effect-of-a-community-based-lat-treated-management-model-on-the-violence-risk-of-patients-with-schizophrenia-123209 https://curecurrent.com/trials/compensatory-cognitive-training-for-schizophrenia-123210 https://curecurrent.com/trials/add-on-hd-hf-trns-over-bilateral-dlpfc-for-treating-patients-with-schizophrenia-123211 https://curecurrent.com/trials/method-of-level-mol-therapy-for-psychosis-123212 https://curecurrent.com/trials/brain-image-markers-associated-with-cognitive-training-and-aerobic-exercise-in-schizophrenia-123213 https://curecurrent.com/trials/nicotine-receptor-density-response-to-nicotine-patch-pt-2-extended-treatment-123214 https://curecurrent.com/trials/study-on-communication-comprehension-in-the-schizophrenic-spectrum-123215 https://curecurrent.com/trials/long-term-study-of-cariprazine-in-patients-with-schizophrenia-123216 https://curecurrent.com/trials/a-long-term-safety-and-tolerability-study-of-alks-3831-in-adults-with-schizophrenia-123217 https://curecurrent.com/trials/creating-live-interactions-to-mitigate-barriers-123218 https://curecurrent.com/trials/first-episode-schizophrenia-and-cannabis-related-disorder-study-123219 https://curecurrent.com/trials/feasibility-and-preliminary-effect-of-baduanjin-program-for-people-diagnosed-with-schizophrenia-123220 https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-bioavailability-between-two-products-containing-paliperidone-100-mg-in-the-form-of-a-pr-123221 https://curecurrent.com/trials/the-impact-of-dietary-habits-and-nutrition-intervention-on-metabolic-syndrome-in-individuals-with-schizophrenia-123222 https://curecurrent.com/trials/rtms-for-working-memory-deficits-in-schizophrenia-123223 https://curecurrent.com/trials/effectiveness-of-second-generation-antipsychotics-in-first-episode-psychosis-patients-3-year-follow-up-123224 https://curecurrent.com/trials/mobile-health-technology-to-enhance-abstinence-in-smokers-with-schizophrenia-123225 https://curecurrent.com/trials/music-therapy-towards-schizophrenia-negative-symptoms-123226 https://curecurrent.com/trials/the-efficacy-and-safety-of-a-selective-estrogen-receptor-beta-agonist-ly500307-for-negative-symptoms-and-cognitive-impai-123227 https://curecurrent.com/trials/memantine-for-the-prevention-of-cognitive-dysfunction-and-negative-symptoms-in-patients-with-acute-schizophrenia-123228 https://curecurrent.com/trials/memantine-for-the-treatment-of-cognitive-dysfunction-and-negative-symptoms-in-patients-with-chronic-schizophrenia-123229 https://curecurrent.com/trials/research-of-anatomo-functional-biomarkers-in-schizophrenia-123230 https://curecurrent.com/trials/prednisolone-addition-for-patients-with-recent-onset-psychotic-disorder-123231 https://curecurrent.com/trials/examining-risk-factors-for-atypical-antipsychotic-metabolic-side-effects-123232 https://curecurrent.com/trials/a-new-paradigm-for-illness-monitoring-and-relapse-prevention-in-schizophrenia-123233 https://curecurrent.com/trials/a-randomised-controlled-trial-of-coenzyme-q10-in-patients-with-schizophrenia-and-schizoaffective-disorder-123234 https://curecurrent.com/trials/safety-and-efficacy-of-cariprazine-rgh-188-in-the-acute-exacerbation-of-schizophrenia-123235 https://curecurrent.com/trials/study-on-predictiors-and-mechanism-of-conversion-to-psychosis-in-individuals-at-ultra-high-risk-group-123236 https://curecurrent.com/trials/comparison-of-ketamine-combine-propofol-vs-propofol-anesthesia-in-schizophrenia-electroconvulsive-therapy-123237 https://curecurrent.com/trials/a-multi-modal-approach-to-addressing-cardiovascular-risk-and-building-resilience-in-youths-with-psychosis-123238 https://curecurrent.com/trials/dyad-oxytocin-study-dos-123239 https://curecurrent.com/trials/piloting-mol-intervention-for-neuroleptic-decision-making-123240 https://curecurrent.com/trials/adult-study-oxytocin-fmri-123241 https://curecurrent.com/trials/effectiveness-of-a-problem-solving-intervention-for-common-adolescent-mental-health-problems-in-india-123242 https://curecurrent.com/trials/oxytocin-meg-study-123243 https://curecurrent.com/trials/adult-oxytocin-study-123244 https://curecurrent.com/trials/effects-of-risperdal-consta-on-ability-to-benefit-from-social-skills-training-in-schizophrenia-123245 https://curecurrent.com/trials/curcumin-as-a-novel-treatment-to-improve-cognitive-dysfunction-in-schizophrenia-123246 https://curecurrent.com/trials/schizophrenia-treatment-with-electric-transcranial-stimulation-123247 https://curecurrent.com/trials/development-of-a-mobile-system-for-self-management-of-schizophrenia-sos-123248 https://curecurrent.com/trials/risperidone-long-acting-versus-oral-risperidone-in-patients-with-schizophrenia-and-alcohol-use-disorder-123249 https://curecurrent.com/trials/evaluation-of-internet-based-cognitive-behavioral-self-help-treatments-for-people-with-psychosis-123250 https://curecurrent.com/trials/the-effect-of-n-acetyl-cysteine-on-cortical-erosion-in-early-stage-schizophrenia-123251 https://curecurrent.com/trials/adaptation-of-cognitive-enhancement-therapy-for-persons-at-clinical-high-risk-for-psychosis-123252 https://curecurrent.com/trials/nicotinic-receptors-and-schizophrenia-123253 https://curecurrent.com/trials/the-mid-term-effect-of-repeated-transcranial-magnetic-stimulation-on-schizophrenia-123254 https://curecurrent.com/trials/study-of-add-on-ramelteon-therapy-on-sleep-and-circadian-rhythm-disruption-in-patients-with-schizophrenia-123255 https://curecurrent.com/trials/high-frequency-rtms-treatment-for-cognitive-impairments-in-chronic-schizophrenia-patients-123256 https://curecurrent.com/trials/transcranial-magnetic-stimulation-to-improve-gesture-control-123257 https://curecurrent.com/trials/alleviating-the-metabolic-side-effects-of-antipsychotic-medications-123258 https://curecurrent.com/trials/study-to-demonstrate-cognitive-enhancing-effects-of-bf2-649-123259 https://curecurrent.com/trials/neurostimulation-enhanced-behavioral-remediation-of-social-cognition-in-schizophrenia-123260 https://curecurrent.com/trials/cognate-patient-care-insight-scale-123261 https://curecurrent.com/trials/impact-of-case-management-on-therapeutic-alliance-with-first-episode-psychosis-patients-camat-123262 https://curecurrent.com/trials/rtms-treatment-for-positive-and-negative-symptoms-of-schizophrenia-123263 https://curecurrent.com/trials/the-benefit-of-minocycline-on-negative-symptoms-in-schizophrenia-extent-and-mechanisms-123264 https://curecurrent.com/trials/the-effects-of-prebiotics-on-cognitive-functioning-and-weight-gain-in-psychosis-123265 https://curecurrent.com/trials/fingolimod-in-schizophrenia-patients-123266 https://curecurrent.com/trials/ketamine-s-effect-changes-the-cortical-electrophysiological-activity-related-to-semantic-affective-dimension-of-pain-123267 https://curecurrent.com/trials/comparison-of-antipsychotic-combination-treatment-of-olanzapine-and-amisulpride-to-monotherapy-123268 https://curecurrent.com/trials/aripiprazole-once-monthly-versus-daily-oral-atypical-antipsychotic-treatment-in-patients-with-recent-onset-schizophrenia-123269 https://curecurrent.com/trials/aripiprazole-abilify-maintena-collaborative-clinical-protocol-123270 https://curecurrent.com/trials/paliperidone-er-invega-on-depressive-symptoms-of-schizophrenia-patients-123271 https://curecurrent.com/trials/a-twelve-week-open-label-extension-study-in-patients-with-schizophrenia-123272 https://curecurrent.com/trials/study-on-abnormal-dopamine-synthesis-and-connectivity-according-to-the-antipsychotic-treatment-response-in-schizophrenia-123273 https://curecurrent.com/trials/validation-of-receptor-occupancy-simulation-123274 https://curecurrent.com/trials/stem-cell-research-on-subjects-at-genetic-high-risk-for-schizophrenia-123275 https://curecurrent.com/trials/pharmacokinetic-study-of-lurasidone-after-multiple-oral-administration-in-healthy-human-subjects-123276 https://curecurrent.com/trials/optimizing-cognitive-remediation-outcomes-in-schizophrenia-123277 https://curecurrent.com/trials/cognitive-remediation-of-schizophrenia-in-a-community-mental-health-setting-123278 https://curecurrent.com/trials/novel-smoking-cessation-drug-for-schizophrenia-123279 https://curecurrent.com/trials/pentosan-polysulfate-sodium-and-meclofenamic-acid-as-treatments-in-patients-with-psychotic-disorders-123280 https://curecurrent.com/trials/positive-emotions-program-for-schizophrenia-peps-123281 https://curecurrent.com/trials/smoking-cessation-with-varenicline-in-schizophrenia-antipsychotic-induced-neurological-symptoms-as-correlates-123282 https://curecurrent.com/trials/compassion-focused-therapy-for-distressing-experiences-123283 https://curecurrent.com/trials/effectiveness-of-the-remedrugby-program-123284 https://curecurrent.com/trials/treatment-of-schizophrenia-and-comorbid-cannabis-use-disorder-comparing-clozapine-to-treatment-as-usual-123285 https://curecurrent.com/trials/the-optimal-treatment-for-treatment-resistant-schizophrenia-123286 https://curecurrent.com/trials/cross-sectional-iloperidone-ivgtt-123287 https://curecurrent.com/trials/an-evaluation-of-a-psychoeducation-program-in-individuals-diagnosed-with-schizophrenia-123288 https://curecurrent.com/trials/effects-of-aripiprazole-lai-on-phychosocial-cognitive-functioning-pt-reported-acceptabilityoftreatment-in-sch-123289 https://curecurrent.com/trials/effects-of-pentazocine-versus-lorazepam-on-manic-symptoms-123290 https://curecurrent.com/trials/rct-examining-the-effectiveness-of-digital-picture-frame-use-in-inpatient-setting-123291 https://curecurrent.com/trials/comparison-of-propofol-target-controlled-infusion-anesthesia-and-bolus-injection-in-electroconvulsive-therapy-123292 https://curecurrent.com/trials/cognitive-remediation-and-sheltered-employment-in-schizophrenia-123293 https://curecurrent.com/trials/the-potential-efficacy-of-the-chinese-health-improvement-profile-a-pilot-clustered-randomised-controlled-trial-123294 https://curecurrent.com/trials/mindfulness-based-social-cognition-training-for-psychosis-socialmind-a-feasibility-study-123295 https://curecurrent.com/trials/safety-and-efficacy-of-pyridoxal-5-phosphate-in-the-treatment-of-tardive-dyskinesia-123296 https://curecurrent.com/trials/early-predictors-of-poor-treatment-response-in-patients-with-schizophrenia-treated-with-atypical-antipsychotics-123297 https://curecurrent.com/trials/monitoring-and-management-for-metabolic-side-effects-of-antipsychotics-123298 https://curecurrent.com/trials/double-blind-trial-of-a-probiotic-supplement-to-reduce-the-symptoms-of-schizophrenia-123299 https://curecurrent.com/trials/a-study-to-examine-safety-pharmacokinetics-and-pharmacodynamic-of-pf-06412562-in-subjects-with-schizophrenia-123300 https://curecurrent.com/trials/waist-circumference-measurements-in-schizophrenic-patients-123301 https://curecurrent.com/trials/target-engagement-for-oxytocin-dose-ranging-study-123302 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-alks-9072-also-known-as-aripiprazole-lauroxil-alks-9070-or-aristada-in-su-123303 https://curecurrent.com/trials/a-double-blind-trial-of-adjunctive-valacyclovir-to-improve-cognition-in-early-phase-schizophrenia-123304 https://curecurrent.com/trials/the-role-of-personal-identity-in-psychotic-symptoms-a-study-with-the-repertory-grid-technique-123305 https://curecurrent.com/trials/efficacy-and-tolerability-study-of-betahistine-to-ameliorate-antipsychotic-associated-weight-gain-123306 https://curecurrent.com/trials/family-intervention-in-recent-onset-schizophrenia-treatment-first-123307 https://curecurrent.com/trials/clinical-trial-of-avl-3288-in-schizophrenia-patients-123308 https://curecurrent.com/trials/glutamate-brain-connectivity-and-duration-of-untreated-psychosis-123309 https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-as-a-treatment-for-cognitive-deficits-in-schizophrenic-123310 https://curecurrent.com/trials/sodium-butyrate-for-improving-cognitive-function-in-schizophrenia-123311 https://curecurrent.com/trials/examining-persistence-in-smokers-with-schizophrenia-123312 https://curecurrent.com/trials/neurophysiological-studies-in-schizophrenia-and-psychiatric-disorders-123313 https://curecurrent.com/trials/curcumin-addition-to-antipsychotic-treatment-in-chronic-schizophrenia-patients-123314 https://curecurrent.com/trials/clinical-evaluation-of-acupuncture-treatment-for-negative-symptoms-of-schizophrenia-123315 https://curecurrent.com/trials/role-of-an-e-cigarette-on-smoking-displacement-in-smokers-with-schizophrenia-123316 https://curecurrent.com/trials/a-pharmacokinetic-study-of-lurasidone-after-single-oral-administration-in-healthy-subjects-123317 https://curecurrent.com/trials/exercise-and-overnight-motor-sequence-task-123318 https://curecurrent.com/trials/treatment-of-alcohol-dependence-and-comorbid-bipolar-disorder-123319 https://curecurrent.com/trials/effectiveness-of-neuroadaptive-cognitive-training-in-adolescents-at-risk-for-psychosis-123320 https://curecurrent.com/trials/probiotics-to-prevent-relapse-after-hospitalization-for-mania-123321 https://curecurrent.com/trials/impact-of-video-presentations-on-medical-students-attitudes-toward-mental-illness-123322 https://curecurrent.com/trials/tocilizumab-as-add-on-treatment-for-residual-positive-negative-and-cognitive-symptoms-of-schizophrenia-123323 https://curecurrent.com/trials/emotional-response-in-psychiatric-and-control-participants-123324 https://curecurrent.com/trials/electronic-decision-support-systems-for-smokers-with-severe-mental-illness-123325 https://curecurrent.com/trials/evaluating-isradipine-for-cognitive-enhancement-in-schizophrenia-and-schizoaffective-disorder-123326 https://curecurrent.com/trials/cognitive-behavioral-therapy-for-the-prevention-of-paranoia-in-adolescents-at-high-risk-123327 https://curecurrent.com/trials/transcranial-magnetic-stimulation-tms-for-patients-with-treatment-resistant-auditory-verbal-hallucination-123328 https://curecurrent.com/trials/a-study-of-aripiprazole-lauroxil-also-known-as-aristada-tm-in-subjects-with-schizophrenia-123329 https://curecurrent.com/trials/cognitive-behavioral-therapy-for-paranoia-in-schizophrenia-123330 https://curecurrent.com/trials/brain-imaging-attention-and-auditory-processing-in-schizophrenia-123331 https://curecurrent.com/trials/randomized-controlled-trial-rct-of-a-motivational-decision-support-system-123332 https://curecurrent.com/trials/transcranial-alternating-current-stimulation-tacs-for-cognitive-impairments-in-patients-with-schizophrenia-123333 https://curecurrent.com/trials/efficiency-study-to-investigate-blonanserin-in-treatment-of-schizophrenia-when-compared-with-risperidone-123334 https://curecurrent.com/trials/staccato-loxapine-single-dose-pk-123335 https://curecurrent.com/trials/a-comparison-of-cognitive-training-approaches-in-psychotic-disorders-123336 https://curecurrent.com/trials/safety-and-efficacy-of-cariprazine-in-schizophrenia-123337 https://curecurrent.com/trials/remote-cognitive-remediation-123338 https://curecurrent.com/trials/study-of-preladenant-for-the-treatment-of-antipsychotic-induced-movement-disorders-in-participants-with-schizophrenia-st-123339 https://curecurrent.com/trials/monotherapy-brexpiprazole-opc-34712-trial-in-the-treatment-of-adults-with-schizophrenia-with-impulsivity-123340 https://curecurrent.com/trials/person-centered-psychosis-care-an-educational-intervention-123341 https://curecurrent.com/trials/study-of-repetitive-transcranial-magnetic-stimulation-in-the-treatment-of-cognitive-impairment-in-schizophrenia-123342 https://curecurrent.com/trials/safety-and-efficacy-of-cariprazine-in-patients-with-schizophrenia-123343 https://curecurrent.com/trials/randomized-double-blind-placebo-controlled-multi-center-and-tolerability-of-rbp-7000-in-schizophrenia-patients-123344 https://curecurrent.com/trials/effects-of-pilates-exercise-program-in-patients-with-schizophrenia-123345 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-oms643762-in-psychiatrically-stable-schizophrenia-subjects-123347 https://curecurrent.com/trials/evaluation-of-the-functional-remission-occurrence-and-predictive-factors-in-schizophrenia-123348 https://curecurrent.com/trials/touchscreen-based-cognitive-tests-in-healthy-volunteers-123349 https://curecurrent.com/trials/adjuvant-treatment-with-a-glycine-uptake-inhibitor-in-participants-with-negative-symptoms-of-schizophrenia-p05695-mk-843-123350 https://curecurrent.com/trials/the-effects-of-bimodal-tdcs-on-illness-severity-insight-functional-outcomes-neurocognition-and-hrv-in-schizophrenia-123351 https://curecurrent.com/trials/do-consumer-providers-enhance-recovery-123352 https://curecurrent.com/trials/d-serine-in-schizophrenia-123353 https://curecurrent.com/trials/evaluation-of-the-necessity-of-long-term-pharmacological-treatment-with-antipsychotics-in-schizophrenic-patients-123354 https://curecurrent.com/trials/characterization-of-emotional-processing-of-information-in-bipolar-disorder-and-schizophrenic-patients-123355 https://curecurrent.com/trials/d-serine-treatment-for-tardive-dyskinesia-123356 https://curecurrent.com/trials/a-trial-of-cognitive-training-in-schizophrenia-123357 https://curecurrent.com/trials/testing-a-new-device-to-advance-the-use-of-social-skills-training-with-mental-health-consumers-and-clinicians-123358 https://curecurrent.com/trials/safety-and-tolerability-of-inp105-olanzapine-by-i231-pod-device-nasal-spray-in-healthy-volunteers-snap-101-123359 https://curecurrent.com/trials/a-proof-of-concept-study-of-intravenous-sodium-nitroprusside-in-adults-with-symptomatic-schizophrenia-123360 https://curecurrent.com/trials/long-term-study-of-rbp-7000-in-the-treatment-of-subjects-with-schizophrenia-123361 https://curecurrent.com/trials/clinical-trial-of-tolcapone-for-cognition-in-schizophrenia-123362 https://curecurrent.com/trials/minocycline-augmentation-to-clozapine-123363 https://curecurrent.com/trials/a-long-term-safety-study-of-alks-9072-also-known-as-alks-9070-123364 https://curecurrent.com/trials/varenicline-effects-in-schizophrenic-smokers-123365 https://curecurrent.com/trials/feasibility-and-relevance-of-high-intensity-functional-training-in-patients-with-first-episode-psychosis-123366 https://curecurrent.com/trials/the-effects-of-progressive-muscle-relaxation-therapy-in-patients-with-schizophrenia-123367 https://curecurrent.com/trials/the-effect-of-hawthorn-on-lipoprotein-cholesterol-ratio-in-schizophrenics-with-antipsychotics-123368 https://curecurrent.com/trials/study-investigating-the-safety-and-tolerability-of-multiple-doses-of-pf-02545920-in-subjects-with-schizophrenia-123369 https://curecurrent.com/trials/comparison-of-combination-olanzapine-lithium-or-chlorpromazine-lithium-in-treatment-of-first-manic-episode-with-psychoti-123370 https://curecurrent.com/trials/combination-of-dronabinol-and-clonidine-for-cannabis-dependence-in-patients-with-schizophrenia-123371 https://curecurrent.com/trials/a-study-of-alks-9072-in-subjects-with-chronic-stable-schizophrenia-123372 https://curecurrent.com/trials/an-open-label-study-of-aripiprazole-lauroxil-in-subjects-with-stable-schizophrenia-123373 https://curecurrent.com/trials/longitudinal-effect-of-electroconvulsive-therapy-on-schizophrenia-and-bipolar-disorder-a-mri-study-123374 https://curecurrent.com/trials/a-novel-treatment-approach-for-self-stigma-in-first-episode-psychosis-123375 https://curecurrent.com/trials/cognitive-remediation-of-autobiographical-memory-in-schizophrenia-using-sensecam-123376 https://curecurrent.com/trials/prospective-cytochrome-p450-genotyping-and-clinical-outcomes-in-patients-with-psychosis-123377 https://curecurrent.com/trials/an-open-trial-of-allopurinol-in-patients-with-poorly-responsive-schizophrenia-123378 https://curecurrent.com/trials/predictors-of-persistence-in-patients-with-schizophrenia-treated-with-once-monthly-aripiprazole-in-spain-123379 https://curecurrent.com/trials/a-study-to-examine-the-safety-tolerability-and-pharmacokinetics-of-pf-02545920-in-psychiatrically-stable-subjects-with-s-123380 https://curecurrent.com/trials/linagliptin-in-schizophrenia-patients-123381 https://curecurrent.com/trials/a-trial-of-folate-with-b12-in-patients-with-schizophrenia-with-residual-symptoms-in-ethiopia-123382 https://curecurrent.com/trials/open-label-study-to-assess-usability-of-the-medical-information-device-1-mind1-system-in-adults-with-schizophrenia-on-or-123383 https://curecurrent.com/trials/mindfulness-psychoeducation-program-for-schizophrenia-123384 https://curecurrent.com/trials/personalised-cognitive-remediation-therapy-pcrt-123385 https://curecurrent.com/trials/cognitive-remediation-therapy-crt-in-adolescents-with-eos-123386 https://curecurrent.com/trials/evaluating-the-efficacy-of-a-late-life-schizophrenia-integrated-care-pathway-to-treat-acute-psychotic-symptoms-123387 https://curecurrent.com/trials/trial-of-treatment-for-internalized-stigma-in-schizophrenia-123388 https://curecurrent.com/trials/can-imagination-change-upsetting-memories-of-trauma-123389 https://curecurrent.com/trials/mobile-enhancement-of-motivation-in-schizophrenia-123390 https://curecurrent.com/trials/recruitment-of-patients-through-invitation-letters-123391 https://curecurrent.com/trials/a-study-of-the-effectiveness-of-cognitive-adaptation-training-in-early-intervention-for-psychosis-123392 https://curecurrent.com/trials/study-of-vitamin-d-in-the-severely-mentally-ill-123393 https://curecurrent.com/trials/prevention-of-weight-gain-and-dyslipidemia-by-green-tea-in-patients-initiating-therapy-with-olanzapine-123394 https://curecurrent.com/trials/schizophrenia-for-life-a-registry-and-interview-study-among-elderly-with-lifelong-schizophrenia-123395 https://curecurrent.com/trials/treatment-of-mania-symptoms-with-drug-therapy-123396 https://curecurrent.com/trials/preventing-relapse-in-schizophrenia-oral-antipsychotics-compared-to-injectables-evaluating-efficacy-123397 https://curecurrent.com/trials/a-study-of-cariprazine-in-the-prevention-of-relapse-of-symptoms-in-participants-with-schizophrenia-123398 https://curecurrent.com/trials/imaging-cannabinoid-cb1-receptors-in-schizophrenia-123399 https://curecurrent.com/trials/e-cigarettes-to-promote-smoking-reduction-among-individuals-with-schizophrenia-123400 https://curecurrent.com/trials/decision-support-for-smoking-cessation-in-young-adults-with-severe-mental-illness-123401 https://curecurrent.com/trials/a-study-of-alks-3831-in-adults-with-acute-exacerbation-of-schizophrenia-the-enlighten-1-study-123402 https://curecurrent.com/trials/from-prevention-to-community-integration-ipcst-for-severe-mental-illness-in-chinese-communities-hong-kong-and-beijing-123403 https://curecurrent.com/trials/effects-of-atypical-antipsychotic-and-valproate-combination-therapy-on-glucose-and-lipid-metabolism-in-schizophrenia-123404 https://curecurrent.com/trials/direct-measurements-of-cardiometabolic-risk-in-treated-schizophrenia-patients-123405 https://curecurrent.com/trials/telmisartan-as-an-adjunctive-treatment-for-metabolic-problems-in-patients-with-schizophrenia-123406 https://curecurrent.com/trials/feasibility-and-acceptability-of-a-smartphone-app-to-assess-early-warning-signs-of-psychosis-relapse-123407 https://curecurrent.com/trials/systematic-evaluation-of-antiviral-medication-in-schizophrenia-123408 https://curecurrent.com/trials/study-to-determine-the-pharmacokinetics-safety-tolerability-of-aripiprazole-in-adults-with-schizophrenia-123409 https://curecurrent.com/trials/augmentation-of-neuronal-network-plasticity-in-schizophrenia-123410 https://curecurrent.com/trials/efficacy-and-safety-study-for-cognitive-deficits-in-adult-subjects-with-schizophrenia-123411 https://curecurrent.com/trials/safety-and-efficacy-study-for-cognitive-deficits-in-adult-subjects-with-schizophrenia-123412 https://curecurrent.com/trials/exercise-and-cognitive-training-123413 https://curecurrent.com/trials/social-cognition-training-in-schizophrenia-123414 https://curecurrent.com/trials/an-inpatient-study-of-the-efficacy-safety-and-tolerability-of-pf-02545920-in-the-treatment-of-acute-exacerbation-of-schi-123415 https://curecurrent.com/trials/using-motivational-techniques-to-increase-levels-of-physical-activity-in-long-term-psychiatric-inpatient-wards-123416 https://curecurrent.com/trials/berberine-effect-on-cytokine-crp-metabolic-disturbance-as-an-adjunctive-therapy-in-schizophrenia-patients-123417 https://curecurrent.com/trials/optimizing-response-in-psychosis-study-123418 https://curecurrent.com/trials/optimization-of-treatment-and-management-of-schizophrenia-in-europe-123419 https://curecurrent.com/trials/cognitive-remediation-for-first-episode-of-psychosis-patients-123420 https://curecurrent.com/trials/salsalate-as-an-adjunctive-treatment-for-patients-with-schizophrenia-123421 https://curecurrent.com/trials/social-cognition-assessment-in-young-adults-123422 https://curecurrent.com/trials/functional-neuroimaging-effects-of-cognitive-remediation-training-123423 https://curecurrent.com/trials/promoting-physical-activity-in-people-with-schizophrenia-123424 https://curecurrent.com/trials/long-term-safety-and-efficacy-of-abt-126-in-subjects-with-schizophrenia-an-extension-study-for-subjects-completing-study-123425 https://curecurrent.com/trials/the-effects-of-tdcs-on-auditory-hallucination-insight-neurocognitive-function-and-hrv-in-patients-with-schizophrenia-123426 https://curecurrent.com/trials/the-effect-of-transcranial-direct-current-stimulation-on-human-brains-a-neuroimaging-study-123427 https://curecurrent.com/trials/stimulation-to-improve-auditory-hallucinations-123428 https://curecurrent.com/trials/transcranial-direct-current-stimulation-influences-on-cognitive-inhibition-in-schizophrenia-123429 https://curecurrent.com/trials/motivation-and-executive-control-in-schizophrenia-123430 https://curecurrent.com/trials/berberine-treat-metabolic-syndrome-in-schizophrenia-123431 https://curecurrent.com/trials/a-shared-decision-making-training-for-inpatients-with-schizophrenia-123432 https://curecurrent.com/trials/correlation-between-clinical-deterioration-in-schizophrenic-patients-and-hair-cortisol-levels-123433 https://curecurrent.com/trials/influence-of-amphetamine-induced-sensitization-on-dopamine-synthesis-and-release-123434 https://curecurrent.com/trials/cognitive-behavior-therapy-for-patients-with-psychoses-123435 https://curecurrent.com/trials/effects-of-physical-activity-in-psychosis-123436 https://curecurrent.com/trials/therapeutic-efficacy-of-transcranial-magnetic-stimulation-in-schizophrenia-123437 https://curecurrent.com/trials/use-of-galantamine-and-cdp-choline-citicoline-to-treat-adults-with-schizophrenia-123438 https://curecurrent.com/trials/very-low-nicotine-cigarettes-in-smokers-with-schizophrenia-123439 https://curecurrent.com/trials/a-d1-agonist-for-working-memory-123440 https://curecurrent.com/trials/assessment-of-cannabis-craving-in-schizophrenia-using-virtual-reality-123441 https://curecurrent.com/trials/brain-circuits-in-schizophrenia-and-smoking-123442 https://curecurrent.com/trials/effects-of-nicotine-on-areas-of-impaired-and-preserved-functioning-in-schizophrenia-123443 https://curecurrent.com/trials/brain-functions-underlying-visuospatial-attention-deficits-in-schizophrenia-123444 https://curecurrent.com/trials/neuroimaging-studies-of-neurophysiological-phenotypes-in-schizophrenia-123445 https://curecurrent.com/trials/folate-supplementation-in-schizophrenia-123446 https://curecurrent.com/trials/clonazepam-effects-on-brain-oscillations-and-cognition-in-schizophrenia-123447 https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-in-treatment-refractory-auditory-hallucinations-123448 https://curecurrent.com/trials/short-term-working-memory-and-executive-training-123449 https://curecurrent.com/trials/evaluation-of-a-visual-remediation-intervention-for-schizophrenia-123450 https://curecurrent.com/trials/include-using-lived-experience-to-improve-mental-health-diagnosis-v1-123451 https://curecurrent.com/trials/pharmacokinetics-and-safety-studies-of-esomeprazole-use-in-schizophrenia-patients-123452 https://curecurrent.com/trials/integrated-metacognitive-therapy-in-first-episode-psychosis-123453 https://curecurrent.com/trials/plantar-sensation-balance-risk-of-falling-and-gait-in-patients-with-schizophrenia-123454 https://curecurrent.com/trials/risperidone-and-desipramine-in-alcohol-use-and-schizophrenia-123455 https://curecurrent.com/trials/evaluation-and-validation-of-social-cognition-battery-to-characterize-schizophrenic-patients-functioning-123456 https://curecurrent.com/trials/normal-and-abnormal-erp-during-tom-and-emotional-conflicts-in-schizophrenia-123457 https://curecurrent.com/trials/alcoholism-and-schizophrenia-effects-of-clozapine-123458 https://curecurrent.com/trials/efficacy-of-quetiapine-in-the-treatment-of-patients-with-schizophrenia-and-a-comorbid-substance-use-disorder-123459 https://curecurrent.com/trials/transcranial-direct-current-stimulation-for-hallucinations-in-first-episode-schizophrenia-123460 https://curecurrent.com/trials/cannabidiol-as-a-different-type-of-an-antipsychotic-drug-delivery-and-interaction-study-123461 https://curecurrent.com/trials/effect-of-n-acetylcysteine-on-brain-glutamate-123462 https://curecurrent.com/trials/improving-cognition-in-schizophrenia-using-tdcs-123463 https://curecurrent.com/trials/clozapine-induced-hypersalivation-feasibility-trial-123464 https://curecurrent.com/trials/scit-versus-tar-for-outpatients-with-schizophrenia-123466 https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-for-the-treatment-of-negative-symptoms-in-schizophrenia-patients-123467 https://curecurrent.com/trials/computer-aided-learning-for-managing-stress-123468 https://curecurrent.com/trials/study-of-immunotherapy-in-autoantibody-positive-psychosis-123469 https://curecurrent.com/trials/pilot-trial-of-valproate-as-adjunctive-treatment-for-toxoplasma-gondii-infection-in-early-course-schizophrenia-123470 https://curecurrent.com/trials/perception-of-facial-emotions-in-schizophrenia-and-22q11-deletion-syndrome-123471 https://curecurrent.com/trials/d-cycloserine-augmentation-of-cognitive-remediation-in-schizophrenia-123472 https://curecurrent.com/trials/assessment-of-adverse-events-in-a-naive-pediatric-population-treated-with-an-antipsychotic-123473 https://curecurrent.com/trials/gender-differences-in-social-cognition-in-patients-with-schizophrenia-of-recent-diagnosis-and-healthy-controls-subjects-123474 https://curecurrent.com/trials/daaoi-2-add-on-treatment-for-treatment-resistant-schizophrenia-123475 https://curecurrent.com/trials/virtual-reality-therapy-for-treatment-resistant-auditory-hallucinations-in-schizophrenia-123476 https://curecurrent.com/trials/characterization-of-the-motivational-deficit-in-schizophrenia-and-depression-123477 https://curecurrent.com/trials/prospective-pharmacogenetic-testing-and-clinical-outcomes-in-patients-with-early-phase-psychosis-123478 https://curecurrent.com/trials/a-pilot-trial-of-curcumin-effects-on-cognition-in-schizophrenia-123479 https://curecurrent.com/trials/long-acting-paliperidone-palmitate-injection-and-olanzapine-for-schizophrenia-123480 https://curecurrent.com/trials/facilitation-of-nmda-receptor-function-in-patients-with-schizophrenia-and-co-morbid-alcoholism-123481 https://curecurrent.com/trials/computerized-cognitive-training-for-schizophrenia-in-brazil-123482 https://curecurrent.com/trials/safety-and-tolerability-study-of-single-dose-administration-of-brexpiprazole-in-adult-subjects-with-schizophrenia-123483